[ Thu, Dec 29th 2022 ]: WOPRAI
[ Thu, Dec 29th 2022 ]: WOPRAI
[ Thu, Dec 29th 2022 ]: WOPRAI
[ Thu, Dec 29th 2022 ]: WOPRAI
[ Thu, Dec 29th 2022 ]: WOPRAI
[ Thu, Dec 29th 2022 ]: WOPRAI
[ Thu, Dec 29th 2022 ]: WOPRAI
[ Wed, Dec 28th 2022 ]: WOPRAI
[ Wed, Dec 28th 2022 ]: WOPRAI
[ Wed, Dec 28th 2022 ]: WOPRAI
[ Wed, Dec 28th 2022 ]: WOPRAI
[ Wed, Dec 28th 2022 ]: WOPRAI
[ Wed, Dec 28th 2022 ]: WOPRAI
[ Tue, Dec 27th 2022 ]: WOPRAI
[ Tue, Dec 27th 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Fri, Dec 23rd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Thu, Dec 22nd 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
[ Wed, Dec 21st 2022 ]: WOPRAI
Matthew Biegler Downgraded (CELU) to Hold on, Dec 22nd, 2022
- 🞛 This publication is a summary or evaluation of another publication
Matthew Biegler of Oppenheimer, Downgraded "Celularity Inc." (CELU) to Hold on, Dec 22nd, 2022.
Matthew has made no other calls on CELU in the last 4 months.
There are 3 other peers that have a rating on CELU. Out of the 3 peers that are also analyzing CELU, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $50 on, Monday, September 12th, 2022
- Asthika Goonewardene of "Truist Securities" Maintained at Hold with Decreased Target to $60 on, Tuesday, August 23rd, 2022
This is the rating of the analyst that currently disagrees with Matthew
- James Molloy of "Alliance Global Partners" Initiated at Strong Buy and Held Target at $150 on, Thursday, August 25th, 2022